Associated Papers
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis.
Hoefflin R et al.
Cancers, 2021
33800365 (PubMed )
Supplement: cancers-13-01151-s001.zip › Supplementary_Data_1.xlsx › S_Data_1
Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology.
Ibarrola-Villava M et al.
Oncotarget, 2016
26968814 (PubMed )
Supplement: oncotarget-07-22543-s001.pdf
High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients.
Tan SH et al.
Plos One, 2015
PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors.
Miselli F et al.
The American Journal of Surgical Pathology, 2008
[Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology, 2006
Select a paper to view details